How We Played Biogen’s Breakout for a 183% Gain

Is your money at stake??

Published: June 10, 2021 Is This the Easiest Trade on Earth?! What if everyday traders never had to stare at a stock chart again? So they could just place a simple trade on Tuesday morning… walk away… And come back Friday to cash out. That means instead of refreshing news headlines over the weekend or stressing about how the markets will open on Monday… They're off for a quick three-day vacation to the beach, a national park or maybe just relaxing! Spend the Long Weekend in Style Lance Ippolito Lance is a professional trader and a successful entrepreneur with over 10 years of experience in the financial markets. How We Played Biogen's Breakout for a 183% Gain Just after the opening bell on Monday, the FDA announced its approval of Biogen's new Alzheimer's drug, Aduhelm. Trading was halted several times as the news shot Biogen shares off like a rocket, gaining 63.5% in just under three hours. Biogen's bullish momentum helped spark a rally across the sector as shares of Eli Lilly and Co. jumped 10% to a record high while Cassava Sciences surged over 9%. This is the first new Alzheimer's drug to be approved in almost two decades, and Wall Street was monitoring the progress closely. Not only were shares pricey, but Biogen's bullish momentum and implied volatility (IV) around the unknown event meant its options chain was ridiculously expensive… But a direct play on Biogen wasn't the only way for traders to get exposure to this blockbuster breakout event... Here's What I Did Instead Car Prices Spiking on Semiconductor Shortage. Here's How to Play It June 7, 2021 The semiconductor shortage bottlenecking production and ramping demand as Americans start to leave their houses, have car prices spiking — especially for used cars... Continue Reading Don't Waste Time on Meme Stocks. This Index Is Screaming 'Action' June 8, 2021 There's an old saying in the stock market: Don't wait for the action, go to the action.… Continue Reading A New Money Crew Publication Disclaimer: The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.  Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment.  Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions. This email was sent to phanhoa1821960.trader@blogger.com by WealthPress LLC 495 Town Plaza Ave | | Jacksonville | FL | 32081 Forward to a friend | Unsubscribe From All WealthPress Emails